HLA-DRB3/4/5-based susceptibility profiles in nivolumab-induced type 1 diabetes and interstitial lung disease.
Saved in:
| Title: | HLA-DRB3/4/5-based susceptibility profiles in nivolumab-induced type 1 diabetes and interstitial lung disease. |
|---|---|
| Authors: | Nishikido S; Department of Endocrinology and Metabolism, Nagasaki University Hospital, Nagasaki, Japan.; Division of Advanced Preventive Medical Science, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan., Mishima H; Department of Human Genetics and Leading Medical Research Core Unit, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan., Yoshiura KI; Department of Human Genetics and Leading Medical Research Core Unit, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan., Sakamoto N; Department of Respiratory Medicine, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan., Ishimoto H; Department of Respiratory Medicine, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.; Department of Insured Medical Care Management, Nagasaki University Hospital, Nagasaki, Japan., Morimoto S; Clinical Research Center, Nagasaki University Hospital, Nagasaki, Japan., Horie I; Department of Endocrinology and Metabolism, Nagasaki University Hospital, Nagasaki, Japan., Akazawa S; Department of Endocrinology and Metabolism, Nagasaki University Hospital, Nagasaki, Japan.; Division of Advanced Preventive Medical Science, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan., Haraguchi A; Department of Endocrinology and Metabolism, Nagasaki University Hospital, Nagasaki, Japan., Tsujiguchi H; Department of Hygiene and Public Health, Faculty of Medicine, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University, Kanazawa, Japan., Hara A; Department of Hygiene and Public Health, Faculty of Medicine, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University, Kanazawa, Japan., Tajima A; Department of Bioinformatics and Genomics, Graduate School of Advanced Preventive Medical Sciences, Kanazawa University, Kanazawa, Japan.; Environmental Stress Research Center (eSRC), Kanazawa University, Kanazawa, Japan., Hosomichi K; Laboratory of Computational Genomics, School of Life Science, Tokyo University of Pharmacy and Life Sciences, Tokyo, Japan., Mukae H; Department of Respiratory Medicine, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan., Kawakami A; Department of Immunology and Rheumatology, Division of Advanced Preventive Medical Science, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan., Abiru N; Division of Advanced Preventive Medical Science, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan. |
| Source: | Frontiers in immunology [Front Immunol] 2026 Jun 02; Vol. 17, pp. 1840622. Date of Electronic Publication: 2026 Jun 02 (Print Publication: 2026). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 42311662 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: HLA-DRB3/4/5-based susceptibility profiles in nivolumab-induced type 1 diabetes and interstitial lung disease. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Nishikido+S%22">Nishikido S</searchLink>; Department of Endocrinology and Metabolism, Nagasaki University Hospital, Nagasaki, Japan.; Division of Advanced Preventive Medical Science, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.<br /><searchLink fieldCode="AU" term="%22Mishima+H%22">Mishima H</searchLink>; Department of Human Genetics and Leading Medical Research Core Unit, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.<br /><searchLink fieldCode="AU" term="%22Yoshiura+KI%22">Yoshiura KI</searchLink>; Department of Human Genetics and Leading Medical Research Core Unit, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.<br /><searchLink fieldCode="AU" term="%22Sakamoto+N%22">Sakamoto N</searchLink>; Department of Respiratory Medicine, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.<br /><searchLink fieldCode="AU" term="%22Ishimoto+H%22">Ishimoto H</searchLink>; Department of Respiratory Medicine, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.; Department of Insured Medical Care Management, Nagasaki University Hospital, Nagasaki, Japan.<br /><searchLink fieldCode="AU" term="%22Morimoto+S%22">Morimoto S</searchLink>; Clinical Research Center, Nagasaki University Hospital, Nagasaki, Japan.<br /><searchLink fieldCode="AU" term="%22Horie+I%22">Horie I</searchLink>; Department of Endocrinology and Metabolism, Nagasaki University Hospital, Nagasaki, Japan.<br /><searchLink fieldCode="AU" term="%22Akazawa+S%22">Akazawa S</searchLink>; Department of Endocrinology and Metabolism, Nagasaki University Hospital, Nagasaki, Japan.; Division of Advanced Preventive Medical Science, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.<br /><searchLink fieldCode="AU" term="%22Haraguchi+A%22">Haraguchi A</searchLink>; Department of Endocrinology and Metabolism, Nagasaki University Hospital, Nagasaki, Japan.<br /><searchLink fieldCode="AU" term="%22Tsujiguchi+H%22">Tsujiguchi H</searchLink>; Department of Hygiene and Public Health, Faculty of Medicine, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University, Kanazawa, Japan.<br /><searchLink fieldCode="AU" term="%22Hara+A%22">Hara A</searchLink>; Department of Hygiene and Public Health, Faculty of Medicine, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University, Kanazawa, Japan.<br /><searchLink fieldCode="AU" term="%22Tajima+A%22">Tajima A</searchLink>; Department of Bioinformatics and Genomics, Graduate School of Advanced Preventive Medical Sciences, Kanazawa University, Kanazawa, Japan.; Environmental Stress Research Center (eSRC), Kanazawa University, Kanazawa, Japan.<br /><searchLink fieldCode="AU" term="%22Hosomichi+K%22">Hosomichi K</searchLink>; Laboratory of Computational Genomics, School of Life Science, Tokyo University of Pharmacy and Life Sciences, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Mukae+H%22">Mukae H</searchLink>; Department of Respiratory Medicine, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.<br /><searchLink fieldCode="AU" term="%22Kawakami+A%22">Kawakami A</searchLink>; Department of Immunology and Rheumatology, Division of Advanced Preventive Medical Science, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.<br /><searchLink fieldCode="AU" term="%22Abiru+N%22">Abiru N</searchLink>; Division of Advanced Preventive Medical Science, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101560960%22">Frontiers in immunology</searchLink> [Front Immunol] 2026 Jun 02; Vol. 17, pp. 1840622. <i>Date of Electronic Publication: </i>2026 Jun 02 (<i>Print Publication: </i>2026). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Research+Foundation]%22">Frontiers Research Foundation] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101560960 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>1664-3224 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2216643224%22">16643224 </searchLink><i>NLM ISO Abbreviation: </i>Front Immunol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42311662 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.3389/fimmu.2026.1840622 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1840622 Titles: – TitleFull: HLA-DRB3/4/5-based susceptibility profiles in nivolumab-induced type 1 diabetes and interstitial lung disease. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Nishikido S – PersonEntity: Name: NameFull: Mishima H – PersonEntity: Name: NameFull: Yoshiura KI – PersonEntity: Name: NameFull: Sakamoto N – PersonEntity: Name: NameFull: Ishimoto H – PersonEntity: Name: NameFull: Morimoto S – PersonEntity: Name: NameFull: Horie I – PersonEntity: Name: NameFull: Akazawa S – PersonEntity: Name: NameFull: Haraguchi A – PersonEntity: Name: NameFull: Tsujiguchi H – PersonEntity: Name: NameFull: Hara A – PersonEntity: Name: NameFull: Tajima A – PersonEntity: Name: NameFull: Hosomichi K – PersonEntity: Name: NameFull: Mukae H – PersonEntity: Name: NameFull: Kawakami A – PersonEntity: Name: NameFull: Abiru N IsPartOfRelationships: – BibEntity: Dates: – D: 02 M: 06 Text: 2026 Jun 02 Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 1664-3224 Numbering: – Type: volume Value: 17 Titles: – TitleFull: Frontiers in immunology Type: main |
| ResultId | 1 |